Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Childhood Acute Lymphoblastic Leukemia
This study has been terminated.
( Terminated by IRB for continuing review )
Study NCT00165087   Information provided by Dana-Farber Cancer Institute

First Received on September 9, 2005.   Last Updated on December 20, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Lymphoblastic Leukemia
Additional conditions recognized in this trial
Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
asparaginase (E. Coli)
asparaginase (Erwina)
dexrazoxane
doxorubicin
Additional drug interventions recognized in this trial
Asparaginase
Razoxane
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Cardiovascular Agents
Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Dana-Farber Cancer Institute
Children's Hospital Boston


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services